Amifostine (WR-2721) selective protection against melphalan genotoxicity.
Buschini A
Leukemia. 14(9):1642-51.
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection.
Di Ianni M
Cancer Gene Ther. 7(6):920-6.
Transforming growth factor beta3 inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis.
Fogli M
Exp Hematol. 28(7):775-83.
Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias.
Bonati A
Cancer Res. 60(3):728-32.
Peripheral blood progenitor cell mobilization in healthy donors receiving recombinant human granulocyte colony-stimulating factor.
Carlo-Stella C
Exp Hematol. 28(2):216-24.
Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.
Rizzo MT
Cancer Res. 59(19):5047-53.
Therapy of molecular relapse in acute promyelocytic leukemia.
Lo Coco F
Blood. 94(7):2225-9.
Recombinant adenoviral vector-lipofectAMINE complex for gene transduction into human T lymphocytes.
Di Nicola M
Hum Gene Ther. 10(11):1875-84.
DNA damage by tobacco smoke and some antiblastic drugs evaluated using the Comet assay.
Poli P
Toxicol Lett. 108(2-3):267-76.
Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells.
Carlo-Stella C
Blood. 93(11):3973-82.